- Home
- RYTM vs SYNA Comparison
RYTM vs SYNA Comparison
Compare RYTM & SYNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RYTM
- SYNA
- Stock Information
- Founded
- RYTM 2008
- SYNA 1986
- Country
- RYTM United States
- SYNA United States
- Employees
- RYTM N/A
- SYNA N/A
- Industry
- RYTM Biotechnology: Pharmaceutical Preparations
- SYNA Computer peripheral equipment
- Sector
- RYTM Health Care
- SYNA Technology
- Exchange
- RYTM Nasdaq
- SYNA Nasdaq
- Market Cap
- RYTM 3.1B
- SYNA 3.2B
- IPO Year
- RYTM 2017
- SYNA 2002
- Fundamental
- Price
- RYTM $59.03
- SYNA $74.64
- Analyst Decision
- RYTM Strong Buy
- SYNA Strong Buy
- Analyst Count
- RYTM 10
- SYNA 11
- Target Price
- RYTM $62.30
- SYNA $99.60
- AVG Volume (30 Days)
- RYTM 701.0K
- SYNA 554.6K
- Earning Date
- RYTM 11-05-2024
- SYNA 11-07-2024
- Dividend Yield
- RYTM N/A
- SYNA N/A
- EPS Growth
- RYTM N/A
- SYNA N/A
- EPS
- RYTM N/A
- SYNA 3.95
- Revenue
- RYTM $112,530,000.00
- SYNA $979,400,000.00
- Revenue This Year
- RYTM $63.95
- SYNA $13.30
- Revenue Next Year
- RYTM $43.24
- SYNA $15.55
- P/E Ratio
- RYTM N/A
- SYNA $18.86
- Revenue Growth
- RYTM 81.55
- SYNA N/A
- 52 Week Low
- RYTM $31.53
- SYNA $67.83
- 52 Week High
- RYTM $68.58
- SYNA $121.37
- Technical
- Relative Strength Index (RSI)
- RYTM 55.82
- SYNA 51.71
- Support Level
- RYTM $55.37
- SYNA $71.24
- Resistance Level
- RYTM $60.79
- SYNA $75.82
- Average True Range (ATR)
- RYTM 3.60
- SYNA 3.09
- MACD
- RYTM -0.27
- SYNA -0.03
- Stochastic Oscillator
- RYTM 52.59
- SYNA 49.60
About RYTM Rhythm Pharmaceuticals Inc.
Rhythm Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in development and commercialization of therapies for patients with rare diseases. It is focused on the development and commercialization of peptide therapeutics for the treatment of gastrointestinal, or GI, diseases, and genetic deficiencies that result in metabolic disorders. The company's product candidate is setmelanotide (RM 493), which is a potent, melanocortin 4, or MC4, receptor agonist for the treatment of rare genetic disorders of obesity caused by MC4 pathway deficiencies. Geographically the company generates its revenue from the United states, Germany, and other with the majority being generated from the United states.
About SYNA Synaptics Incorporated $0.001 Par Value
Synaptics Inc is a producer of semiconductor solutions for the mobile, PC, and Internet of Things markets. The company develops human interface solutions that enable touch, display, fingerprint, video, audio, voice, AI, and connectivity functions for smartphones, PCs, Internet of Things products, and other electronic devices. Geographically, it derives a majority of revenue from China. The company operates in one segment: the development, marketing, and sale of semiconductor products used in electronic devices and products.